EMCDDA Strategy 2025
Submitted by Edie
- 29 January 2021
This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better-informed drug policy and action.
Adopted unanimously by the agency’s key stakeholders in 2016, the strategy is the result of a year-long, in-depth analysis of the environment in which the EMCDDA operates.
This analysis focused, in particular, on customer needs and a critical review of our internal capacity to meet them.
Links
